BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17311212)

  • 1. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
    Idoate MA; Echeveste J
    Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Towards a molecular classification of gliomas].
    Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
    Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.
    Walker C; du Plessis DG; Joyce KA; Machell Y; Thomson-Hehir J; Al Haddad SA; Broome JC; Warnke PC
    Clin Cancer Res; 2003 Oct; 9(13):4841-51. PubMed ID: 14581356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF; Prayson RA; Barnett GH; Weil RJ
    Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW; Broholm H; Laursen H
    Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two types of chromosome 1p losses with opposite significance in gliomas.
    Idbaih A; Marie Y; Pierron G; Brennetot C; Hoang-Xuan K; Kujas M; Mokhtari K; Sanson M; Lejeune J; Aurias A; Delattre O; Delattre JY
    Ann Neurol; 2005 Sep; 58(3):483-7. PubMed ID: 16130103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subclassification of diffuse gliomas: seeing order in the chaos.
    Huse JT; Phillips HS; Brennan CW
    Glia; 2011 Aug; 59(8):1190-9. PubMed ID: 21446051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological classification of brain tumors.
    Pollo B
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology of gliomas].
    Ducray F
    Cancer Radiother; 2008 Nov; 12(6-7):663-8. PubMed ID: 18838326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
    Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
    Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
    Kujas M; Lejeune J; Benouaich-Amiel A; Crinière E; Laigle-Donadey F; Marie Y; Mokhtari K; Polivka M; Bernier M; Chretien F; Couvelard A; Capelle L; Duffau H; Cornu P; Broët P; Thillet J; Carpentier AF; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2005 Aug; 58(2):322-6. PubMed ID: 16049942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular changes in brain tumors: prognostic and therapeutic impact.
    Sanson M; Laigle-Donadey F; Benouaich-Amiel A
    Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
    Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.